Pharmaceuticals and self-care products manufacturer Perrigo Company plc is preparing to sell its prescription pharmaceuticals business (Rx) to Altaris Capital Partners for $1.55 billion. The investment firm announced Monday that both companies have entered into an agreement on the transaction.
“I am thrilled that we are working with Altaris to establish Perrigo’s Rx business as an independent company,” Sharon Kochan, the president of the business, said in a release. “This is a very important and exciting milestone that will enable us to focus on executing our ambitious plans and growth strategy. Altaris’ healthcare specialization and experience with similar business separations will bring unique, fresh and relevant perspectives as we embark on the next phase of our journey.”
Perrigo Sheds Prescription Pharmaceuticals Business packagingdigest.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from packagingdigest.com Daily Mail and Mail on Sunday newspapers.
Pharmaceuticals and self-care products manufacturer Perrigo Company plc is preparing to sell its prescription pharmaceuticals business (Rx) to Altaris Capital Partners for $1.55 billion. The investment firm announced Monday that both companies have entered into an agreement on the transaction.
“I am thrilled that we are working with Altaris to establish Perrigo’s Rx business as an independent company,” Sharon Kochan, the president of the business, said in a release. “This is a very important and exciting milestone that will enable us to focus on executing our ambitious plans and growth strategy. Altaris’ healthcare specialization and experience with similar business separations will bring unique, fresh and relevant perspectives as we embark on the next phase of our journey.”
Perrigo sells prescription drugs division
file photo
and last updated 2021-03-02 10:34:10-05
DUBLIN â Altaris Capital Partners announced Tuesday that itâll acquire the prescription pharmaceuticals division of Perrigo for $1.55 billion.
The acquisition is expected to close sometime in calendar year 2021, subject to customary closing conditions, a news release said.
After the transaction closes, Perrigo Rx, which has locations in Allegan, Holland and Grand Rapids, will be renamed and headquartered in downtown Grand Rapids.
âI am thrilled that we are working with Altaris to establish Perrigoâs Rx business as an independent company,â said Sharon Kochan, president of Rx. âThis is a very important and exciting milestone that will enable us to focus on executing our ambitious plans and growth strategy. Altarisâ health care specialization and experience with similar business separations will bring unique, fresh and relevant perspectives as we embark o